Top compounds associated with response to NTN5


Feature Type Standardized
Nominal ANOVA
mRNA thalidomide CTRPv2 pan-cancer AAC -0.058 0.3
mRNA Tamoxifen GDSC1000 pan-cancer AAC -0.035 0.3
mRNA MK-0752 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA AZD0530 CTRPv2 pan-cancer AAC 0.038 0.3
mRNA vincristine CTRPv2 pan-cancer AAC 0.031 0.3
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.03 0.3
mRNA fluvastatin CTRPv2 pan-cancer AAC -0.037 0.3
mRNA BRD-K35604418 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA SU11274 CTRPv2 pan-cancer AAC 0.036 0.3
mRNA R428 CTRPv2 pan-cancer AAC 0.044 0.3
Download CSV